The scientists at Miramax have apparently been working in the lab late at night coming up with an idea for an eerie sight. And what they’ve come up with is adapting someone else’s. The studio is ...

For years, MASH was where drug development dreams went to die. One trial after another failed. Companies bowed out. The field earned a reputation as one of biopharma’s most intractable challenges: a ...

Metabolic-associated steatohepatitis (MASH) happens when excess fat in the liver causes inflammation and scarring, or fibrosis. The condition is serious, and when left untreated it can lead to ...

Hall of Fame quarterback Dan Marino recently revealed that he was diagnosed with metabolic dysfunction-associated steatohepatitis, or MASH. The Miami Dolphins legend said the discovery came years ago ...

There are two FDA-approved medications for the metabolic disorder known as MASH. Roche is paying $2.4 billion to acquire 89bio and its late-stage MASH drug, giving the Swiss pharmaceutical giant the ...

Roche dived into the metabolic dysfunction-associated steatohepatitis (MASH) space by agreeing to hand over up to $3.5 billion for 89bio and its phase-3-stage candidate for the fatty liver disease. At ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — Roche on Thursday said it would buy 89bio, the maker of an ...

The whiskey delivers honey, burnt sugar, and smoky vanilla notes. Michter’s Distillery has announced the release of its US*1 Toasted Barrel Finish Sour Mash Whiskey. Set to arrive this September, the ...

Drug developers with products targeting a liver condition called metabolic dysfunction-associated steatohepatitis (MASH) traded higher on Wednesday after the U.S. FDA said it has accepted an ...

Tony Sachs has written for numerous publications about spirits and the people who make them since 2007, and traveled the globe to witness the processes firsthand. Michter’s has evolved from a defunct ...